Introduction
A marked variation from patient to patient has been observed in the proliferative activity of human marrow leukemic cell populations as measured by the per cent of cells incorporating tritiated thymidine (labeling index) and by the mitotic index. A difference of labeling index between blood and bone marrow leukemic cell populations in the same patient has already been reported (1, 2) . This difference is due to a decreased number of dividing leukemic cells in the blood.
The variation of proliferative activity found in the marrow cell compartments in acute leukemia has not been explained. The changes could in part be caused by diurnal variation of proliferative activity or alterations of generation times for the dividing cells. The leukemic marrow is composed of both dividing and nondividing elements (3) ; therefore changes in the proportion of dividing cells could also account for the observed variation.
The following studies were done to document the variation of proliferative activity and to attempt to ascribe a cause for it. The results of the studies indicate that changes in the proportion of dividing cells are primarily responsible for the observed variation.
Methods
Thirty-one children with acute leukemia, ranging in age from 1 to 14 years, were studied. All studies were in accordance with standards for clinical research established at our institution. As determined by morphological criteria (4), 5 patients had acute myeloblastic leukemia (AML), and the rest had acute lymphoblastic leukemia (ALL). The patients studied at the time of diagnosis were untreated; those seen in relapse had had all therapy discontinued before study. In only 7 of the 43 studies were the bone marrows less than 90% replaced by leukemic blast cells. Labeling indexes were determined by both in vivo and in vitro techniques. The mitotic index was measured in 15 patients.
In vitro studies. The mitotic index was determined by a modification of the method reported by Japa (5) . One ml of marrow aspirated into a siliconized syringe was placed on a watch glass and immediately covered with acetocarmine solution. After 10 minutes marrow particles were transferred to glass slides. A cover slip was applied and sealed with silicone grease. Cover slips were tapped gently to spread the cells. Nuclear ma- Bone marrow samples were obtained from four separate pelvic sites at 6-hour intervals during a 24-hour period (6:00 a.m., noon, 6:00 p.m., and midnight). No premedication was given but sites were well infiltrated with local anesthetic. In vitro labeling and mitotic indexes were determined for each time period.
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The resulting data were subjected to an analysis of variance to determine the probability that the observed variations in mitotic index and per cent of cells incorporating tritiated thymidine could have occurred by chance. A p value < 0.05 was considered significant. The Student range test was applied at the 5% significance level to obtain the minimal significant change (K) of the indexes (6a).
Dividing and nondividing leukemic cells. The dividing and nondividing leukemic cells may be identified by morphologic criteria (3) . Dividing blast cells are large with fine nuclear chromatin and nondividing blast cells are small with coarse nuclear chromatin. Only the large dividing cells incorporate label during a 1-hour incubation with tritiated thymidine. The leukemic cells were arbitrarily designated as being large or small in 10 studies on 5 patients based on their relative size and according to the characteristics of nuclear chromatin. The significance of the changes in labeling indexes and proportions of large blast cells was determined by means of Student's t test (6b). more, in order to minimize the possible effect of label reutilization. The background grain count in acellular areas was 2 grains in a size similar to cell nuclei. In these studies the labeling index of the marrow was determined by the per cent of labeled cells in the 1-hour sample.
Results
In an attempt to establish that an in vitro labeling index reflects proliferative activity in vivo, There was no correlation of labeling indexes with age or sex of the patient, type of leukemia, duration of survival from diagnosis, degree of marrow replacement with leukemic cells, or blood leukemic blast cell concentration. However, in the 9 patients with labeling indexes greater than 6%o at the time of diagnosis, the duration of symptoms was less than 2 weeks. Conversely, patients with symptoms more than 2 weeks in duration at time of diagnosis had labeling indexes less than 6%o. Beyond this observation, no direct statistical correlation between labeling indexes and duration of symptoms could be developed (6c).
Ten patients who were studied at the time of diagnosis were restudied in one or more subsequent relapses. The changes in labeling indexes are shown in Figure 3 . In 8 patients a significant increase in labeling from diagnosis to the first relapse was found (p < 0.001). One patient having no change in labeling at the first relapse had a marked increase at the time of a second relapse (p < 0.001). In one patient a decrease in labeling was found at relapse (p < 0.01) and in another a decrease from first to second relapse was observed (p <0.001). To follow changes in labeling during a single relapse, we obtained labeling indexes a week apart in one patient who was receiving no therapy. The first index was 9.8 0.7%o and the second 9.4 + Diurnal variation. A statistically significant diurnal variation of mitotic indexes was found in 5 of the 6 patients studied (Table III ). In 4 of the patients (no. 1, 2, 3, 4) the mitotic index was greatest at 6:00 p.m. or midnight as found in normal subjects (7) . In Patient 6 the greatest value was at noon. There was no significant variation in Patient 5, whose marrow contained very few mitotic figures.
A small, although significant, variation in labeling indexes was found in 4 of the 6 patients (Table IV). In Patients 4 and 6, the labeling index In the patient with no variation of mitotic index a significant variation of thymidine uptake was found, and in the 2 patients having no variation of thymidine uptake a significant variation in mitotic index was found. All patients, therefore, had significant variation in one or both of their measurements of proliferative activity.
Changes in proportion of dividing cells. In 4 of the patients having multiple studies it was possible to follow changes in the proportion of dividing leukemic cells from diagnosis to subsequent relapses. As shown in Table V , in each patient an increase or decrease in the labeling index of the marrow leukemic cell population was associated with a corresponding increase or decrease in the proportion of large dividing cells. Labeling of the large cells varied from 34 to 50%o. The strong correlation of labeling indexes with proportion of dividing cells is shown in Figure 4 
Discussion
The use of tritiated thymidine and its evaluation as a cell label in vivo (8, 9) and in vitro (10) The presence of a diurnal variation of proliferative activity could affect interpretation of kinetic data. Myeloid elements of normal human marrow have a diurnal variation of proliferation as shown by mitotic and labeling indexes (7) . A diurnal variation of thymidine uptake was not present in leukemic cells from blood (11) , which, however, is generally not a proliferative compartment in acute leukemia (1, 2) . Some experimental malignart tumors in animals maintain cyclic proliferative activity (12, 13) . All 6 patients studied for diurnal variation of proliferative activity had a statistically significant diurnal variation in one or both measures. However, the magnitude of variation was insufficient to explain the wide range of proliferative activity found in these 31 patients. (13) . From the data on the small number of patients studied, no such consistently optimal time for daily therapy in human leukemia was found. It is of interest that in 4 patients studied, a diurnal variation of mitotic indexes like the normal pattern (7) was found, suggesting that the cells are responsive to some of the usual mechanisms controlling cell division.
The use of tritiated thymidine in vivo to determine generation times of leukemic cells presents many problems (8, 9) . Patients may be submitted to a limited number of marrow aspirations. The resulting data may be difficult to interpret because of the loss of -some labeled cells into background after division and label reutilization (14, 15) . Only a minimal generation time can be obtained from the time course for labeled mitotic figures. It is reasonable that a range of generation times for dividing leukemic cells may exist in the same patient. The failure of the per cent of labeled mitotic figures to decrease to zero after the first wave of mitoses and the incomplete development of the second wave of labeled mitoses would support this hypothesis. Furthermore, heavily labeled mitotic figures indicative of first or second generation cells have been found as late as 210 hours after label injection (16) . Thus, some leukemic cells may have a prolonged rest phase after the initial mitosis, appearing as heavily labeled mitotic figures 200 hours later. In spite of the above limitation, it appears that the minimal generation time for dividing leukemic blast cells was similar at diagnosis and in relapse in the 3 patients studied.
The relationship between blast size and thymidine uptake has been noted previously (3, 17, 18) . A strong positive correlation was found between the labeling index of the marrow cell population and the proportion of large, dividing blast cells. Therefore it is most reasonable to explain the observed variation in proliferative activity of marrow leukemic cell populations by changes in the proportion of dividing cells within those populations.
The proliferative activity of leukemic marrow was greater in relapse than at time of diagnosis. The patients in relapse were studied early in relapse, whereas patients seen for the first time at diagnosis may have been studied comparatively late in the development of their disease. It is of interest in this regard that patients with high labeling-indexes at the time of diagnosis had relatively short duration of symptoms. Ehrlich ascites tumor cells in mice have a progressive decrease in labeling and mitotic indexes after implantation due to an accumulation of nondividing cells (19) . The presence of nondividing blast cells in human leukemia has been demonstrated by several investigators (2, 3, 17) . The changes found in the proliferative activity of human leukemic marrow cell populations may also be due to an accumulation with time of nondividing cells. So far the available kinetic studies do not distinguish the nondividing cell from a cell having a very prolonged interphase.
If this concept is correct, then the labeling index of leukemic marrow cells should decrease as the patient is followed in relapse without therapy. In one patient so studied, a decrease in marrow cell labeling could not be demonstrated over a 1-week period. However, the patient may have been studied too late in the period of "tumor maturation," or 1 week may have been an inadequate period of time to produce a significant change in proliferative activity.
